Rank-ordered PFS by DFMO dose, ODC genotype and urinary polyamines.

Alyssa VanderWerff (745743); André S. Bachmann (745758); Deanna Mitchell (745750); Don Eslin (745747); Eugene W. Gerner (745740); Genevieve Bergendahl (745741); Giselle L. Saulnier Sholler (745739); Jacqueline M. Kraveka (745748); Jeffrey P. Bond (108228); Joel Kaplan (745749); Kathleen Neville (745752); Kyoko Hiramatsu (745756); Leonard Sender (745753); Masao Kawakita (745755); Nehal S. Parikh (745751); Randal K. Wada (745746); Robert B. MacArthur (745742); Shun-suke Moriya (745757); Takamaru Ashikaga (745744); Timothy Higgins (745754); William Ferguson (745745); William Roberts (497062)

Abstract

*PF = progression free, PD = progressive disease2nd Leukemia = secondary leukemia**Substrates for the tissue polyamine exporter SLC3A2 include the sum of putrescine, N1AcSpd, N8AcSpd and DAS; D1C1 = day 1, cycle 1, D8C1 = day 8 cycle 1***NA = samples not availableRank-ordered PFS by DFMO dose, ODC genotype and urinary polyamines.</p

Similar works

Full text

Available Versions

FigShare

oai:figshare.com:article/14277...

Last time updated on 12/02/2018